Hepatitis C: New Models and New Insights
Charles Rice Ph.D.
Professor, Laboratory of Virology and Infectious Disease
Caspary Auditorium May 16 2011 4 p.m.
Washburn ML; Bility MT; Zhang LG, et al. 2011. A humanized mouse model to study Hepatitis C virus infection, immune response, and liver disease. Gastroenterology. 140(4):1334-1344.
Dring MM; Morrison MH; McSharry BP, et al. 2011. Innate immune genes synergise to predict increased risk of chronic disease in hepatitis C virus infection. PNAS. 108(14):5736-5741.
Barnaba V. 2010. Hepatitis C virus infection: a “liaison a trios” amongst the virus, the host, and chronic low-level inflammation for human survival. Journal of Hepatology. 53(4):752-761.
Berrueta L; Salmen S. 2010. Immune tolerance at 50 years from the Nobel Prize in Medicine and Physiology: A perspective as a mechanism of immune response against pathogens. Investigacion Clinica. 51(2):159-192. Please request this article from Markus Library.
Walker, CM. 2010. Adaptive immunity to the hepatitis C virus. Book Series: Advances in virus research. Volume 78. Pp. 43-86..
Murray CL; Rice CM. 2010. Hepatitis C: an unsuspected drug target. Nature. 465(7294):42-44.
Chockalingam K; Simeon RL; Rice CM, et al. 2010. A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle. PNAS. 107(8):3764-3769.
Rehermann B. 2009. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution andcoexistence. Journal of Clinical investigation. 199(7):1745-1754.